Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

298 Press Releases
DateTitleCompany
26 Sep 16 Sanofi : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika Sanofi,
Published by
GlobeNewswire
26 Sep 16 Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA Sanofi,
Published by
GlobeNewswire
22 Sep 16 Data on Treatment Effects with Lemtrada® (alemtuzumab) Over Six Years in People with Relapsing Remitting Multiple Sclerosis to be presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London Sanofi Genzyme
19 Sep 16 Sanofi Files Suit in U.S. to Defend Paten Rights on Lantus® and Lantus® Solostar® Sanofi,
Published by
GlobeNewswire
16 Sep 16 Sanofi Presents New Data for an Investigational Fixed-Ratio Combination of Insulin Glargine and Lixisenatide at the European Association for the Study of Diabetes 52nd Annual Meeting Sanofi ,
Published by
PharmiWeb.com
15 Sep 16 Results from 1,000-Patient, Global Real-World Patient-Reported Outcomes Study of Sanofi Genzyme’s Aubagio® (teriflunomide) in Patients with Relapsing Multiple Sclerosis Demonstrate High Levels of Treatment Satisfaction Sanofi Genzyme,
Published by
Business Wire
15 Sep 16 Toujeo® Demonstrates a More Stable Profile and Lower Within-day Variability Compared to Insulin Degludec Sanofi,
Published by
PR Newswire
13 Sep 16 Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform Sanofi,
Published by
PharmiWeb.com
13 Sep 16 Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone Sanofi,
Published by
PharmiWeb.com
13 Sep 16 Sanofi's Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone Sanofi,
Published by
GlobeNewswire
01 Sep 16 Alberta includes LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients Sanofi Genzyme,
Published by
PR Newswire
27 Aug 16 New Brunswick includes LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients Sanofi Genzyme,
Published by
PharmiWeb.com
23 Aug 16 Sanofi : Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of th... Sanofi,
Published by
GlobeNewswire
19 Aug 16 Sanofi Provides Update on New Drug Application for Investigational Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Sanofi,
Published by
GlobeNewswire
13 Aug 16 Sanofi: Dengue Immunization Public Program in Paraná State of Brazil Set To Achieve WHO 2020 Ambition Sanofi,
Published by
GlobeNewswire
01 Aug 16 Sanofi and Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab Sanofi ,
Published by
PharmiWeb.com
01 Aug 16 Sanofi and Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab Sanofi Genzyme,
Published by
PR Newswire
29 Jul 16 Sanofi : Online Availability of Sanofi Group's Half-Year Financial Report for 2016 Sanofi,
Published by
GlobeNewswire
14 Jun 16 Sanofi Announces Reduction in HbA1c using an Investigational Fixed-Ratio Combination of Insulin Glargine 100 units/mL and Lixisenatide Versus Comparators Insulin Glargine 100 units/mL or Lixisenatide Sanofi ,
Published by
PharmiWeb.com
27 Jun 16 Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi's Animal Health and Boehringer Ingelheim's Consumer Healthcare businesses Sanofi,
Published by
GlobeNewswire
14 Jun 16 The Sanofi Canada Healthcare Survey Explores the Workplace's Impact on Health Sanofi-aventis Canada Inc.,
Published by
PR Newswire
23 Jun 16 New Four-Strain Influenza Vaccine, VaxigripTetra™, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe Sanofi Pasteur,
Published by
PR Newswire
06 Jul 16 Sanofi Pasteur Signs Research Agreement for Zika Vaccine Sanofi,
Published by
GlobeNewswire
06 Jul 16 Sanofi Genzyme Begins Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients with Acid Sphingomyelinase Deficiency Sanofi Genzyme,
Published by
Business Wire
26 Jul 16 Sanofi Pasteur MSD's new four-strain influenza vaccine now approved in the UK Sanofi Pasteur MSD UK ,
Published by
PharmiWeb.com
21 Jul 16 Ontario adds LEMTRADA® (alemtuzumab) to the Exceptional Access Program for eligible patients Sanofi Genzyme,
Published by
PR Newswire
28 Jul 16 Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
05 Jul 16 Saskatchewan includes LEMTRADA® (alemtuzumab) on MS Drugs Program for eligible patients Sanofi Genzyme,
Published by
PR Newswire
29 Jul 16 Sanofi Announces Q2 2016 Results Sanofi,
Published by
PR Newswire
05 Jul 16 Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information Sanofi,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.